Aggregometry and thromboelastography to identify the timing to trach a COVID‐19 patient receiving both antiplatelet therapy and enoxaparin

Aggregometry and thromboelastography to identify the timing to trach a COVID‐19 patient receiving both antiplatelet therapy and enoxaparin

Abstract In COVID‐19 patients receiving enoxaparin and antiplatelets therapy, aggregometry and thromboelastography might be considered an adjunctive tool to identify the time to perform procedures at risk of bleeding, such as tracheostomy.

Bibliographic Details
Main Authors: Marco Tescione, Eugenio Vadalà, Graziella Marano, Andrea Bruni, Eugenio Garofalo, Ovidia Lavalle, Federico Longhini, Enzo Battaglia, Nicola Polimeni, Demetrio Labate, Sarah Caracciolo, Francesco Giordano, Massimo Caracciolo, Sebastiano Macheda
Format: Article
Language:English
Published: Wiley 2021-03-01
Series:Clinical Case Reports
Subjects:
aggregometry
COVID‐19
SARS‐CoV‐2
thromboelastography
tracheostomy
Online Access:https://doi.org/10.1002/ccr3.3442

Internet

https://doi.org/10.1002/ccr3.3442

Similar Items